Neuromodulation for Lennox-Gastaut Syndrome: Interview with Martha Morrell, M.D., CMO of NeuroPace
NeuroPace, a medtech company based in California, has developed the RNS system, an implantable neuromodulation device for focal drug-resistant epilepsy. The system continuously monitors brain activity and then responds appropriately to target the sei...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Neurology Neurosurgery Lennox-Gastaut neuropace Source Type: blogs
More News: Brain | Child Development | Deep Brain Stimulation | Emergency Medicine | Epilepsy | Genetics | Medical Devices | Neurology | Neurosurgery | Psychology | Study | Vagus Nerve Stimulation Therapy